Search Results - "Esquerre, Mariana Muñoz"

Refine Results
  1. 1

    High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study by López-Sánchez, Marta, Muñoz-Esquerre, Mariana, Huertas, Daniel, Gonzalez-Costello, José, Ribas, Jesús, Manresa, Federico, Dorca, Jordi, Santos, Salud

    Published in PloS one (27-06-2013)
    “…A subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). To evaluate the…”
    Get full text
    Journal Article
  2. 2

    Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease by Muñoz-Esquerre, Mariana, López-Sánchez, Marta, Escobar, Ignacio, Huertas, Daniel, Penín, Rosa, Molina-Molina, María, Manresa, Frederic, Dorca, Jordi, Santos, Salud

    Published in PloS one (05-04-2016)
    “…Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic atherosclerosis and pulmonary vascular remodelling characterized by…”
    Get full text
    Journal Article
  3. 3

    Impact of the implementation of a telemedicine program on patients diagnosed with asthma by Cabrerizo-Carreño, Héctor, Muñoz-Esquerre, Mariana, Santos Pérez, Salud, Romero-Ortiz, Ana Maria, Fabrellas, Núria, Guix-Comellas, Eva Maria

    Published in BMC pulmonary medicine (13-01-2024)
    “…Asthma is one of the most common respiratory ailments worldwide. Despite broad understanding of the illness and of the available therapeutic options for it,…”
    Get full text
    Journal Article
  4. 4

    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD by Aliagas, Elisabet, Muñoz-Esquerre, Mariana, Cuevas, Ester, Careta, Oriol, Huertas, Daniel, López-Sánchez, Marta, Escobar, Ignacio, Dorca, Jordi, Santos, Salud

    Published in Respiratory research (28-05-2018)
    “…Extracellular adenosine triphosphate (ATP) is up-regulated in the airways of patients with chronic obstructive pulmonary disease (COPD), resulting in increased…”
    Get full text
    Journal Article
  5. 5

    Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine) by Muñoz-Esquerre, Mariana, Aliagas, Elisabet, López-Sánchez, Marta, Escobar, Ignacio, Huertas, Daniel, Penín, Rosa, Dorca, Jordi, Santos, Salud

    Published in PloS one (18-05-2017)
    “…The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not fully understood…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both by Pfeffer, Paul E., Ali, Nasloon, Murray, Ruth, Ulrik, Charlotte, Tran, Trung N., Maspero, Jorge, Peters, Matthew, Christoff, George C., Sadatsafavi, Mohsen, Torres‐Duque, Carlos A., Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al‐Ahmad, Mona, Larenas‐Linnemann, Désirée, Kuna, Piotr, Fonseca, João A., Al‐Lehebi, Riyad, Rhee, Chin Kook, Perez‐de‐Llano, Luis, Perng Steve, Diahn‐Warng, Mahboub, Bassam, Wang, Eileen, Goh, Celine, Lyu, Juntao, Newell, Anthony, Alacqua, Marianna, Belevskiy, Andrey S., Bhutani, Mohit, Bjermer, Leif, Bjornsdottir, Unnur, Bourdin, Arnaud, Bulow, Anna von, Busby, John, Canonica, Giorgio Walter, Cosio, Borja G., Dorscheid, Delbert R., MuñozEsquerre, Mariana, FitzGerald, J. Mark, Gil, Esther Garcia, Gibson, Peter G., Heaney, Liam G., Hew, Mark, Hilberg, Ole, Hoyte, Flavia, Jackson, David J., Koh, Mariko Siyue, Ko, Hsin‐Kuo Bruce, Lee, Jae Ha, Lehmann, Sverre, Chaves Loureiro, Cláudia, Lúðvíksdóttir, Dóra, Menzies‐Gow, Andrew N., Mitchell, Patrick, Papaioannou, Andriana I., Popov, Todor A., Porsbjerg, Celeste M., Salameh, Laila, Sirena, Concetta, Taillé, Camille, Taube, Christian, Tohda, Yuji, Wechsler, Michael E., Price, David B.

    Published in Allergy (Copenhagen) (01-07-2023)
    “…Background Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Sudan red dye: a new agent causing type-2 occupational asthma by Clofent, David, de Homdedeu, Miquel, Muñoz-Esquerre, Mariana, Cruz, María Jesús, Muñoz, Xavier

    Published in Allergy, asthma, and clinical immunology (30-01-2020)
    “…Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight azoic agent widely used in industry, particularly in the production of hair dyes…”
    Get full text
    Journal Article
  11. 11

    Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation by Santos, Salud, Marin, Alicia, Serra-Batlles, Joan, de la Rosa, David, Solanes, Ingrid, Pomares, Xavier, López-Sánchez, Marta, Muñoz-Esquerre, Mariana, Miravitlles, Marc

    “…Exacerbations of COPD represent an important medical and health care problem. Certain susceptible patients suffer recurrent exacerbations and as a consequence…”
    Get full text
    Journal Article
  12. 12

    Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients by Careta, Oriol, Cuevas, Ester, Muñoz-Esquerre, Mariana, López-Sánchez, Marta, Pascual-González, Yuliana, Dorca, Jordi, Aliagas, Elisabet, Santos, Salud

    Published in Scientific reports (26-02-2019)
    “…Growing evidence indicates that purinergic signalling is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD) and in the vascular…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Roflumilast added to triple therapy in patients with severe COPD: A real life study by Muñoz-Esquerre, Mariana, Diez-Ferrer, Marta, Montón, Concepción, Pomares, Xavier, López-Sánchez, Marta, Huertas, Daniel, Manresa, Frederic, Dorca, Jordi, Santos, Salud

    Published in Pulmonary pharmacology & therapeutics (01-02-2015)
    “…Abstract Background Roflumilast is used in severe chronic obstructive pulmonary disease (COPD) patients with frequent exacerbations. However, limited…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients by Muñoz-Esquerre, Mariana, Huertas, Daniel, Escobar, Ignacio, López-Sánchez, Marta, Penín, Rosa, Peinado, Victor, Barberà, Joan Albert, Molina-Molina, María, Manresa, Frederic, Dorca, Jordi, Santos, Salud

    Published in Lung (01-06-2015)
    “…Purpose Fibronectin (Fn) and tenascin-C (TnC) are two extracellular matrix proteins associated with remodeling changes. Fn and TnC gene and protein expression…”
    Get full text
    Journal Article
  19. 19

    Vascular disease in COPD: systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine) by Muñoz Esquerre, Mariana, Aliagas Marín, Elisabeth, López Sánchez, Marta, Escobar Campuzano, Ignacio, Huertas, Daniel, Penín, Rosa, Dorca i Sargatal, Jordi, Santos Pérez, Salud

    Published in PloS one (18-05-2017)
    “…Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not…”
    Get full text
    Journal Article
  20. 20

    Highlights del 55.° Congreso SEPAR by Amaya Martínez Meñaca, Esther Barbero Herranz, Mariana Muñoz-Esquerre, Marta Marín-Oto, Marta García Moyano, Juan Alejandro Cascón-Hernández, Tamara Alonso Pérez

    Published in Open respiratory archives (01-01-2023)
    “…Resumen: El 55.° Congreso SEPAR, celebrado en Pamplona del 2 al 4 de junio de 2022, volvió a ser, una vez más, la reunión científica de referencia para los…”
    Get full text
    Journal Article